In modern biopharmaceutical manufacturing, flexibility, sterility, and supply security are more important than ever. During the COVID-pandemic, manufacturers and CMDO’s were faced with supply-chain challenges. It appeared that moving to a second supplier was possible, but not easy. Read more [Picture source:
Flowmeister B.V. on linkedin.com]
